Onderneming Hansoh Pharmaceutical Group Company Limited Börse Stuttgart
Aandelen
3KY
KYG549581067
Farmaceutische producten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,975 EUR | -3,19% | 0,00% | +19,30% |
Vakgebied
- verkoop van farmaceutische producten (99,1%);
- verkoop van onderzoeks- en ontwikkelingsdiensten (0,9%).
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Oncology
61,1
%
| 6 421 | 58,9 % | 6 817 | 61,1 % | +6,16% |
Central Nervous System Diseases
13,5
%
| 1 737 | 15,9 % | 1 511 | 13,5 % | -13,05% |
Metabolic Diseases and Others
12,9
%
| 1 299 | 11,9 % | 1 435 | 12,9 % | +10,51% |
Anti-infective Diseases
12,6
%
| 1 452 | 13,3 % | 1 402 | 12,6 % | -3,46% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 10 911 | 100,0 % | 11 165 | 100,0 % | +2,33% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 02-12-15 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 31-05-19 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 14-06-19 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 02-12-15 |
Ai Feng Lyu
BRD | Director/Board Member | 47 | 11-03-16 |
Yu An Sun
BRD | Director/Board Member | 38 | 02-12-15 |
Bedrijfsgegevens
Hansoh Pharmaceutical Group Co., Ltd.
287 Xiangke Road Pudong New District
201210, Shanghai
+
http://www.hspharm.comSector
Verkoop per activiteit
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,93% | 803 mld. | |
-7,08% | 351 mld. | |
+17,40% | 324 mld. | |
+10,58% | 303 mld. | |
+16,49% | 243 mld. | |
+1,88% | 228 mld. | |
+10,11% | 217 mld. | |
+6,24% | 164 mld. | |
-4,79% | 155 mld. |
- Beurs
- Aandelen
- Koers 3692
- Koers 3KY
- Onderneming Hansoh Pharmaceutical Group Company Limited